News

PTC Therapeutics DMD Treatment Now Available in Germany

PTC Therapeutics, Inc. has just announced its novel protein restoration therapy Translarna™ (ataluren) is now available to patients with Duchenne Muscular Dystrophy (DMD) in Germany, which is the first European Union country to offer the drug. The first batch of shipments are expected to roll out this week.

Catalent and Valerion Therapeutics Collaborate to Bring New Treatments for Orphan Genetic Disorders to Market

Somerset, N.J. based Catalent Pharma Solutions, specialists in efficient delivery technology and development of medical and health care product solutions is collaborating with Valerion Therapeutics, LLC of Concord, Massachusetts – whose corporate focus is on bio-therapeutics for orphan genetic disease development. The alliance will join forces to develop Valerion’s…

PPMD and Santhera Partner Up on Duchenne Risks Study

Parent Project Muscular Dystrophy (PPMD) has partnered with Swiss pharmaceutical company Santhera Pharmaceuticals to conduct a collaborative study on the benefits and risks of Duchenne muscular dystrophy therapies. The researchers, which will use data from Santhera’s phase 3 clinical trial of idebenone, will be focused on determining…

Sarepta to Host Webcast on Duchenne Muscular Dystrophy Novel Therapy

Sarepta Therapeutics Inc. has announced that it will host a webcast and conference call dedicated specifically to the Duchenne muscular dystrophy (DMD) community, as the company is dedicated to the development of novel RNA-based therapies for the treatment of the genetic and disabling disease. The webcast and conference will take place on Tuesday, December…

UCLA Professor Crosbie-Watson Granted Coalition Duchenne Lotus Award

Newport Beach-based Coalition Duchenne has granted its 2014 Lotus Award to professor Rachelle Crosbie-Watson from the University of California, Los Angeles (UCLA) in recognition of her outstanding work in education, research, and awareness for Duchenne muscular dystrophy. The award also includes a $10,000 grant, which will be given to the Center for Duchenne Muscular Dystrophy at…

Kennedy Krieger Institute Named PPMD Certified Duchenne Care Center

The Kennedy Krieger Institute in Baltimore, Maryland has been granted Certified Duchenne Care Center status by the Parent Project Muscular Dystrophy (PPMD) advocacy group. The institute is the fifth institution to receive the designation, which recognizes its dedication to the improvement of healthcare services for patients suffering from Duchenne muscular dystrophy. Along with the…